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Abstract
The discovery of radiation has led to many advances. Guidelines have been 
created to minimize radiation exposure and treatment management following 
both unintentional and intentional exposure. The effects of radiation exposure on 
specific tissues varies. Tragic consequences can result, ranging from severe, acute 
injury to long- lasting effects that present years after the initial exposure. In this 
chapter we provide observations that demonstrate the importance of understanding 
guidelines to minimize radioactive exposure and the expectations and treatment 
management following exposure. For the safety and well-being of patients, health 
care professionals need to remain well-informed to minimize the risks of this tool.
Keywords: radiation injury, emergency care and treatment
1. Introduction
Our understanding of toxicity associated with exposure to radiation has 
increased since the discovery of X-rays in 1895. X-rays were used to treat a variety 
of malignant and non-malignant diseases. The effects of radioactive exposure on 
specific tissues can vary. Radioactive particles destroy or impair tissue by generating 
free radicals that damage important molecular structures, such as DNA. Radiation 
exposure can lead to catastrophic consequences, ranging from severe, acute injury 
to long-lasting effects that manifest years after the initial exposure. This chapter 
provides observations that demonstrate the importance of understanding guide-
lines to minimize radioactive exposure, and the expectations and treatment man-
agement following exposure [1–3].
Exposure to radioactive particles is divided into intentional or unintentional 
causes. Notable intentional causes include the atomic weapons activated on Hiroshima 
and Nagasaki in Japan during World War II. The immediate injuries and fatalities 
were from the heat and mechanical force generated by the trauma and physical 
destruction. However, it became apparent that there were longer lasting conse-
quences. Survivors in the surrounding area were exposed to high levels of radiation 
and suffered from acute toxicity injuries and organ failure. Many of those who did not 
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succumb to the effects of acute toxicity were known to suffer lifelong chronic condi-
tions, such as developmental problems in newborns and increased cancer risk [4–6].
Unintentional causes are usually the result of radiation exposure without intent 
to injure. These unintentional causes are typically related to the effects of radioac-
tive materials utilized for energy or medical treatment. The first radiograph was 
taken in 1895 and early pioneers in the field were unaware of the consequences of 
exposure. Initial procedures were often associated with unintentional exposure 
and were fraught with numerous complications such as skin blistering, hair loss and 
systemic toxicity that we now know were due to radiation toxicity. These signs and 
symptoms were similar to those present in exposed workers in the first nuclear 
development programs, many of whom would later develop injuries and cancers as 
a consequence of their profession [7, 8].
Despite these risks, nuclear power continues to be used for its benefits. 
Fortunately, we now know much more about how to avoid and minimize radioac-
tive exposure. Rigorous standards enforcing safe practices with radioactive material 
and the formation of numerous regulatory agencies such as the Nuclear Regulatory 
Commission are a testament to how far we have come [9]. However, accidents 
involving radioactive material do occur. In this chapter, we describe a brief history 
of well-known incidents involving unintended radioactive exposure, as well as the 
clinical consequences and care of the patient following exposure.
2. Unintended causes: nuclear accidents
One of the most significant nuclear accidents in history was Chernobyl. On 
that day, a series of missteps during a routine safety check resulted in a massive 
explosion that sent a plume of radioactive material into the air for an entire week. 
The range of this explosion extended well beyond the immediate vicinity, exposing 
other parts of Europe to radioactive gas in the process. In addition to exposing civil-
ians to the radioactive material, first responders also received significant radiation 
levels and thermal injury, many of which were lethal. More recently, the nuclear 
reactor in Fukushima, Japan experienced a meltdown following the 2011 tsunami in 
Japan. While there were no immediate casualties, there was lasting environmental 
damage and the long-term health consequences are yet to be fully understood 
[8]. These examples demonstrate the importance of proper safety measures and 
 providing an effective response to nuclear accidents.
3. Acute toxicity
Toxicity from radiation exposure can be divided into three types: acute, sub-
acute and chronic/late. Acute radiation toxicity is defined as signs and symptoms 
≤90 days following exposure. In a medical setting, treatment of acute exposure 
is quite common. During radiation therapy, radiation is targeted and delivered 
to tumors and management of side effects from the radiation exposure remains a 
mainstay of modern oncology.
The radioactive dose from these procedures is typically far less than the dose 
following unintended exposures outside of the clinical setting. The radiation treat-
ment dose is usually fractionated, meaning the dose is given in intervals to reduce 
the short-term toxicity of the radioactive treatment. The clinical manifestations 
of acute toxicity following a radioactive accident may be much more severe than 
those typically encountered by most physicians and may warrant treatment in an 
 emergency setting [4, 5].
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Acute radiation toxicity involves many organ systems, including but not limited 
to the central nervous, gastrointestinal, and cardiovascular systems. Cells with 
self-renewal potential may be able to recover better from radiation damage com-
pared to those without such protective mechanisms. Self-renewal processes are 
often accelerated as a response to injury where slowly proliferative tissues cannot. 
However, if the exposure is given in a single fraction of high enough dose, this 
ability for self-renewal potential will be overwhelmed. For example, a single total 
body dose >10 Gy will result in death within days from numerous possible causes. 
Damage to the central nervous system will result in cerebrovascular syndrome, with 
uncontrollable swelling in neuromuscular tissue. Despite best supportive care there 
are no medical interventions to prevent death at this level of exposure. Damage to 
the gastrointestinal system results in severe diarrhea and associated fluid loss. The 
mechanism involves depletion of most stem cells within the gastrointestinal crypts. 
Since these stem cells are required to replace the mucosal surface, these mucosal 
surfaces will disappear a few days after exposure and there will be no barrier to 
prevent fluid loss or bacterial entrance into the bloodstream. As a result, patients 
will typically present with fever, nausea, vomiting, fatigue, anorexia, and severe 
hypotension. Doses of 4–5 Gy are enough to cause death from depleted stem cells in 
the hematopoietic system without support. Those that survive the initial depletion 
typically succumb to infection a month later due to depleted lymphocytes and other 
immune elements. These manifestations can occur minutes after exposure, with 
severity being proportional to dose and a sharp decrease in lymphocytes within two 
days of exposure [1, 4, 5].
Should the patient be exposed to doses below 4 Gy, symptomatic and best 
supportive treatment is recommended. Nausea and vomiting are the typical initial 
symptoms and should be treated with hydration. If the exposure dose is unknown, 
noting the time of onset of vomiting is important as exposure dose is inversely 
proportional to time to emesis. It is not uncommon for patients at low exposure 
doses to feel fine for a few weeks before the gastrointestinal and hematopoietic 
symptoms drive a patient to seek medical care. Upon initiation of care, isolation 
and contact inhibition is vital since infection is a major contributor towards death 
in these patients as depletion of the hematopoietic system occurs. Blood transfusion 
and antibiotics can be delivered to alleviate these issues. A patient will often also 
present with skin injury burns at the site of radiation exposure as epidermal and 
dermal injury associated with stem cell depletion can mimic and appear similar to a 
thermal injury. These injuries should be treated promptly, as they are easy routes for 
infection to occur, which can be devastating to a patient with a compromised hema-
topoietic system. In patients with high exposure doses, end of life care is a possible 
consideration. At an exposure of 5 Gy, only about half of patients will survive after 
30 days. An exposure of 10 Gy is considered lethal regardless of medical interven-
tions [1, 5, 6]. Treating patients following radiation exposure is not only challenging 
in terms of clinical aspects, but emotionally as well.
Compounds that have been developed to reduce and even prevent the clinical 
manifestations following radiation exposure are called mitigators. These com-
pounds work by altering the molecular response following radiation exposure. 
As such, a mitigator could inhibit lymphocyte recruitment at sites of radiation 
damage, increase proliferation of stem cells that would normally be inhibited by 
radiation exposure, or inhibit fibrosis. An example of a mitigator is Palifermin, 
a growth factor that stimulates cell growth in response to radiation exposure to 
reduce recovery time. Radioprotectors, on the other hand, are given before or 
immediately after radiation exposure to protect against the effects of radiation 
toxicity [10, 11]. Amifostone is one such radioprotector that has been approved by 
the FDA for reducing side effects from radiation therapy [12]. More mitigators and 
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radioprotectors are expected to be approved as the need to protect against radiation 
toxicity increases. Although many compounds have been and are in development, 
no others to date are actively used in clinical practice and the role of both hemato-
poietic and mesenchymal transplant remains under investigation.
4. Subacute and late toxicity
The subacute and/or late effects of radiation toxicity, by nature, are less visible 
and harder to identify for most emergency and primary care physicians. Often, 
these effects take many years to develop and are often mistaken as sequelae from 
another disease. However, they are nevertheless important to identify and address. 
A common misconception is that the degree to which a patient suffers from acute 
symptoms is proportional to severity of the long-term response. Unfortunately, 
patients who experience little to no acute sequela can experience serious long-term 
sequela, and vice versa. While both children and adults can experience the effects of 
late radiation toxicity, children are susceptible as they have a much longer period for 
these clinical manifestations to develop [13]. Unlike acute toxicity effects, anticipat-
ing long term effects is much more difficult. This technique relies heavily not only 
on a physician’s knowledge of potential long-term effects, but also their willingness 
to investigate a potential long-term effect.
5. Organ specific injury
A common theme in radiation injury is the ability of the tissue or organ to 
respond to cell death and self-regenerate. These aspects vary among organs and 
thus the clinical presentation and treatment is different depending on the organ 
involved. Injuries and treatment protocols for specific organs are as follows:
5.1. Hematopoietic system
As previously discussed, damage to the hematopoietic system typically results 
from injury to progenitor cells, which can lead to hematopoietic crisis and infection. 
Fortunately, with the exception of whole-body exposure, the hematopoietic system 
is generally able to recover from radiation damage due to migration of stem cells 
from outside the site of exposure. Patients who are also receiving chemotherapy or 
taking medications that may result in immunosuppressed states should be carefully 
assessed. In the case of total body irradiation, an immediate decrease in circulat-
ing lymphocytes can be expected with subsequent defects in immune response. 
Symptomatic treatment, including blood infusions and antibiotics as needed, with 
isolation are crucial in these situations [13, 14]. Use of bone marrow transplants to 
replenish depleted progenitor cells has a theoretical survival benefit opportunity in 
total body irradiation patients, but to date has not been embraced as standard prac-
tice and often only applied to those most severely affected. The risk of graft-vs-host 
disease makes this approach controversial, especially in the setting of an emergency 
unrelated allogeneic transplant [6].
5.2. Skin
The skin is often the most direct site of radiation injury, as the epidermis covers 
all other organs and is susceptible to radiation damage. The dermal stem cells are 
the most susceptible component of the skin, as these are the actively dividing cells 
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that replace other cells in the rest of the organ. Early symptoms of exposure typi-
cally involve erythema and swelling as vasodilation and the recruitment of inflam-
matory components localize to the area. These symptoms typically resolve within a 
month. Late term effects include decreased wound healing capacity with increased 
fibrosis and ulceration. Interestingly, the skin will appear to be more vascular-
ized with more prominent vasculature. However, this is due to thinning of the 
epidermis, which causes veins to appear more prominent. Proper wound care is the 
standard treatment for these manifestations, with surgical debridement as needed. 
Particular concern must be paid for patients with medical conditions that are prone 
to fibrosis, such as those with dermatitis, lupus, and scleroderma. Skin infections, 
such as cellulitis, are particularly dangerous given the immunosuppressive effects of 
radiation therapy. Lastly, an interesting phenomenon occurs in some patients where 
previously irradiated skin can become erythemic and fibrotic several years later in 
response to certain medications like antibiotics and chemotherapy. The mechanism 
behind this phenomenon is unknown [15].
In the past, skin involvement from radiation therapy that could not be treated 
with topical ointments was relatively rare. However, with the increasing use of 
hypofractionation (radiation therapy with greater amounts of dose per treatment), 
these findings are becoming more common [16]. Thus, radiation damage to the 
skin is likely to become more prominent in the future as therapy becomes more 
compressed with higher doses delivered in a shorter period of time. Patients with 
a history of radiation therapy and significant skin sequalae should be carefully 
observed for more serious developments as injuries in treated tissues heal less well 
and contain less local immunity.
5.3. Gastrointestinal system
Like the skin, the gastrointestinal system is composed of mucosal cells with 
multiple layers underneath that are constantly replaced over time. Unfortunately, the 
rate at which some of these cells are replaced is higher than that of the skin, leading to 
more immediate and sometimes more severe clinical manifestations. Cells of the gas-
tric and small bowel tend to have the highest rate of replacement, leading to very early 
nausea if these regions were exposed. Exposure to mucosal cells in the upper gastro-
intestinal system (mouth, esophagus, salivary glands) tend to present with clinical 
symptoms around two weeks after exposure due to a longer replacement rate. Damage 
to these cells tends to present with more localized pain and swelling. Exposure to the 
salivary glands can result not only with localized pain, but also xerostomia (dryness of 
mouth) and ageusia (loss of taste). Saliva can become more acidic which can further 
injure normal tissue and alter the environment of the oral cavity. Regardless of these 
manifestations, patients should be advised to maintain adequate nutrition and dental 
hygiene, as this practice helps mitigate the complications of an immunocompromised 
state. Symptomatic treatment of localized pain is also advised and considered stan-
dard of care as bone exposure can be a serious consequence of mucosal denudation 
[14]. Figure 1 represents modern head/neck radiation therapy treatment plan through 
the oral cavity demonstrating sparing of the parotid tissue with intensity modulation.
Farther along the digestive tract, the expected symptoms can be predicted based 
on the location of the tumor. Radiation exposure to the gastric mucosa during treat-
ment of gastric tumors can result in near immediate nausea given the daily replace-
ment the gastric mucosa. Treatment of esophageal tumors, which are now more 
commonly in the lower third of the esophagus, present with a timeline of symptoms 
similar to head and neck tumors (approximately two weeks after exposure). 
Tumors in this region typically cause dysphagia and anorexia. Treatment initially 
tends to relieve patient symptoms, but later patients may return thinking the tumor 
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has returned when in reality these symptoms are due to swelling from the therapy. 
Like head and neck tumors, patients should be advised to continue maintaining 
adequate hydration and nutrition [13, 14].
Symptoms from radiation exposure in the small and large bowel are more 
complex and require more in-depth patient history and laboratory tests. The small 
bowel absorbs much of the nutrients from food. Damaging the microvilli of the 
mucosal surface, which are vital for nutrient absorption, can result in severe malab-
sorption regardless of a patient’s appetite. These findings can be confirmed by stool 
tests. Patients will often present to the emergency room with diarrhea, steatorrhea, 
bloating and general abdominal pain a few days after radiation exposure. The large 
bowel plays an important role in absorption of water, and exposure of large portions 
of this organ may compromise this function. Patients may complain of increased 
defecation frequency, which can lead to dehydration and electrolyte abnormalities 
that can be confirmed through electrolyte panels. To make matters more difficult, 
abdominal organs are prone to forming adhesions after surgical interventions, 
which disrupts blood flow to portions of the bowel that are exacerbated after 
concurrent radiation therapy. Anticipation of these issues through a careful patient 
history are vital to preventing severe complications from occurring [13, 14, 17].
Late effects of radiation also depend on location of the exposure. The mucosal 
cells of the oral cavity should theoretically recover like that of typical skin cells, but 
the combination of a tight space and harsh oral environment prone to infection and 
necrosis makes healing difficult. Thus, fibrosis and ulceration over a long period 
of time are possible. Acute effects of radiation typically damage mucosa of the 
gums and affect the pH of the saliva, facilitating microbial growth. These changes 
can lead to long-term problems with dental hygiene and patients should modify 
their dental habits accordingly through increased tooth brushing and fluoride 
mouthwash [13, 14]. Motility issues are also becoming more common, especially 
since patients who receive radiation therapy are now living longer. Dysphagia 
appears to be due to edema surrounding constrictor muscles, and physical therapy 
Figure 1. 
Parotid sparing. Image courtesy of the Department of Radiation Oncology, University of Massachusetts 
Medical School.
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to encourage lymph drainage offers symptomatic treatment [18]. Gastric emptying 
issues due fibrosis at the gastric antrum and regions in the bowel where surgery was 
performed are also possible years after treatment. Atrophy of the pancreas many 
years after radiation exposure is also known to happen, although the clinical rel-
evance of this is unknown [13, 14]. Symptoms can mimic malabsorption syndrome.
5.4. Lung
The main mechanism of radiation injury in the lungs is the generation of free 
oxygen and nitrogen radicals which damage the lung parenchyma with irregu-
lar repair of type I and II pneumocytes along the delicate reticulin network of 
pulmonary parenchyma. This oxidative damage causes disorganized repair and 
replacement of these cells associated with late fibrosis, impairs the ability for the 
lungs to oxygenate the blood. Pneumocyte damage also leads to recruitment of pro-
inflammatory modulators that recruit immune cells to the region, leading to fibrosis 
and further depleting oxygenation capacity [19]. Furthermore, the radiation-driven 
production of nitric oxide has been suggested as a possible cause of damage to lung 
parenchyma outside of the field of radiation [20].
Complicating this situation is that many chemotherapeutic agents given with 
radiation therapy, such as bleomycin, also causes pulmonary fibrosis. The results 
of these sequelae are the development of pneumonitis up to two to six months after 
exposure. If asymptomatic, careful observation is standard of care. If symptomatic, 
the patient usually presents with occasional bouts of cough and dyspnea. Treatment 
with corticosteroids, supplementary oxygen, and prophylactic antibiotics are 
recommended in this situation. Once the pneumonitis resolves, fibrosis typically 
marks the site of radiation injury and can result in limited ventilation requiring long 
term use of supplemental oxygen. Given these findings, it is important to note that 
these patients tend to be at higher risk of developing chronic pulmonary disease 
compared to those who were unexposed [13, 21–24]. Pulmonary rehabilitation is an 
important aspect to survivorship care and optimizing respiratory health is impor-
tant to each patient as the rehabilitate from therapy. Figure 2 represents changes in 
lung parenchyma associated with immunotherapy and low dose radiation therapy 
with improvement seen after withdrawal of the immunotherapy.
5.5. Liver
Radiation injury to the liver, also known as radiation-induced liver disease 
(RILD), is unique in that it is often during the healing process that tissue function 
undergoes disorganized repair, including injury to the reticulum network, and lim-
its the vascular relationship to the hepatocyte. While acute damage to hepatocytes 
affects liver function, as the cells divide during repair they tend to become disor-
ganized, particularly if the structural reticulum of the liver is damaged. Increased 
distance between the hepatocytes and the blood supply leads to decreased liver 
function. This phenomenon explains why the state of the liver before exposure to 
radiation also plays an important role in this process. For example, a cirrhotic liver 
due to heavy alcoholic use or hepatitis will likely have pre-existing disorganized 
architecture, making this liver more susceptible to radiation damage. This includes 
veno-occlusive disease which also separates vascular anatomy from the hepatocyte. 
For these reasons, imaging studies such as magnetic resonance imaging before the 
delivery of radiation are obtained for evaluation of anatomy and function [25]. 
Disorganized repair can lead to migration of infusional therapies including radiola-
beled therapy as the vascular anatomy can be disrupted and limit efficacy in spite of 
placement of therapy in close approximation to disease.
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Patients with RILD typically experience symptoms that mimic cirrhosis, which 
include abdominal pain, elevated liver enzymes, jaundice, and ascites within four 
months of radiation exposure. Livers with pre-existing damage typically have 
earlier onset, with more severe symptoms. Treatment is symptomatic with keen 
observation of potential veno-occlusive and metabolic disease secondary to a 
congested liver with decreased function. Careful consideration must be given for 
medications that are metabolized in the liver, especially chemotherapeutic agents 
that are also hepatotoxic [25, 26].
5.6. Renal
All components of the kidney, including structures crucial for filtration, such 
as cells of the glomerulus, are susceptible to radiation damage. The signs of acute 
radiation damage are usually seen within 3–18 months, typically mimicking signs 
of renal failure. These signs include decreased glomerular filtration rate (GFR), 
increased serum β2-microglobulin, albuminuria, and other markers of poor renal 
function. Later signs of kidney radiation damage, which include hypertension 
and eventual renal failure, are often hard to distinguish from other pathological 
causes. For treatment of these sequelae, the use of hypertension medications such 
as angiotensin-converting-enzyme inhibitors (ACE) inhibitors are theoretically 
beneficial. Monitoring of renal function, both short and long term, also remains 
crucial in the standard of care for these patients [27–29]. In aging patients who are 
Figure 2. 
(A) and (C) Therapy driven pneumonitis outlining the radiation therapy field while on immune check point 
inhibition. (B) and (D) Improvement after immunotherapy withdrawal. Courtesy of the Department of 
Radiation Oncology, University of Massachusetts Medical School.
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not candidates for surgery, radiation therapy with stereotactic techniques is being 
used more frequently to treat sub-total renal volumes for renal malignancies in an 
effort to spare as much renal function as possible.
5.7. Cardiovascular system
The mechanism of radiation damage to the heart and blood vessels involves 
immediate cellular damage followed by fibrotic and disorganized repair, leading to 
reduced function in all cardiac segments including electrical conduction, myocar-
dium, valves, and vascular anatomy. The time period is variable due to differences 
in size and functional architecture. However, what is clear is that unintended radia-
tion exposure to the heart and blood vessels has a strong association with cardio-
vascular disease and complications [30–33]. The lack of mitigation and therapeutic 
strategies in response to radiation of cardiovascular tissues explains why  radiation 
oncologists spend such a large amount of effort to minimize  cardiovascular 
 exposure [34].
Generous radiation exposure to the heart can result in acute pericarditis. This 
diagnosis should always be in the differential in a patient with history of radiation 
exposure who presents with sharp, radiating chest pain that is relieved when sitting 
up. Anti-inflammatory medications like aspirin, colchicine and prednisone can 
offer symptomatic relief, with pericardiocentesis being an option in severe cases. 
Long term, patients who receive radiation exposure to the heart have a higher 
risk of heart disease and use of echocardiograms and nuclear stress tests in these 
patients is recommended if symptoms warrant use. Large blood vessels like the 
aortic, carotid, and femoral arteries can experience hyperplasia and atherosclerotic 
change from radiation doses. These changes can result in rupture and fistula forma-
tion, necessitating immediate treatment. This usually requires very high doses and 
prolonged exposure usually not seen in modern radiation therapy [30–33]. With 
improvements in survival, patients can receive therapy with intentional overlap to 
previously treated volumes for second malignancies. These patients are vulnerable 
to vascular injury, including larger arteries and survivorship plans need to include 
periodic surveillance of vessels to optimize follow up care. Figure 3 demonstrates 
cardiac sparing for left-sided breast cancer treatment with breath-hold treatment 
techniques and optical tracking.
Figure 3. 
Cardiac sparing with deep inspiration breath-hold (DIBH), (left-free-breathing (FB); right-DIBH). Image 
courtesy of the Department of Radiation Oncology, University of Massachusetts Medical School.
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5.8. Nervous system
Since most cells of the nervous system do not typically have a high turnover rate, 
it would seem reasonable to assume that the nervous system is more resistant to 
radiation damage than other organs. However, this assumption does not account for 
the immediate molecular effects of radiation. Regardless of the rate of cell division, 
all cells will receive damage to membranes, organelles, and other structures within 
the cell. Cells that do not divide very frequently will have to endure these injuries 
for long periods of time, leading to eventual clinical manifestations. Damage to 
nearby vasculature also limits growth and healing of these structures, leading to 
pronounced long term effects. There are clear reports of radiation damage to the 
central nervous system sometimes long after the initial radiation exposure [35–38].
Patients who received radiosurgery or hypofractionation techniques are at risk of 
developing necrosis within six months of receiving therapy. Clinically, these develop-
ments can result in focal changes and change in behavior depending on the site of 
necrosis. Demyelinating syndromes, although rare, are also possible in the peripheral 
nerves and spinal cord. Often, neurotoxic symptoms are enhanced by chemothera-
peutic agents, such as vinblastine, vincristine and cisplatin. Gathering a detailed 
physical exam, medical history and possible neurological referral may be required for 
definitive identification of these outcomes. Patients who received radiation therapy 
for pituitary adenomas or at sites near the optic structures are at risk for visual changes 
[36, 37]. This is because some structures, such as the lens and optic chasm, are sensi-
tive to radiation exposure due to limited blood supply [15, 39, 40]. Patients treated 
for breast and head and neck cancers may rarely present with brachial plexopathy. 
Peripheral lymph nodes for these regions are often within the same field of treatment 
as the brachial plexus, resulting in unintended exposure to this region [41].
5.9. Endocrine
The effect of radiation therapy on the endocrine glands varies depending on the 
gland affected. The timeline for the development of clinical sequelae varies, with 
some cases even being reported many years after the radiation exposure. The pitu-
itary gland is relatively radiation sensitive and results in panhypopituitary syndrome, 
requiring supplementation of depleted hormones. Secondary malignancies from 
un-intentional radiation exposure, while rare, have been reported [42]. Patients who 
received previous head and neck radiation therapy who now present with headache, 
vision loss and/or hormonal abnormalities should be carefully examined for the 
development of pituitary adenomas. The thyroid gland is also sensitive to radiation 
therapy, resulting in hypothyroid syndromes. Patients who receive radiation therapy 
to the head and neck often receive surgery that involves dissection of the thyroid 
gland, exasperating thyroid function loss. The thyroid also has a relatively higher 
incidence of developing secondary malignancies. This finding has been identified 
not only in patients receiving radiation therapy, but also victims of the Chernobyl 
incident [5]. The same care must be given to the parathyroid glands, given the prox-
imity to the thyroid gland, which can present with signs and symptoms of hypopara-
thyroidism. Radiation exposure to the endocrine pancreas and adrenal glands are less 
characterized and are thought to be more radiation resistant. However, there are a 
few cases of injury to these organs associated with radiation exposure [42].
5.10. Reproductive
The reproductive organs are highly sensitive to radiation damage, with early 
exposure in pediatric patients leading to severe detriments like sterility and 
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secondary malignancies (see Pediatrics). Since much of the reproductive system 
depends on hormonal homeostasis, radioactive effects on the endocrine system 
(see Endocrine) and the subsequent effect on hormone production, such as that on 
testosterone and estrogen, can drastically affect reproductive function and develop-
ment depending on the effected hormone and gland. When investigating radiation 
injury to the reproductive system, it is always important to consider the location of 
exposure and any endocrine glands involved. Germ cells, such as spermatogonia, 
are particularly sensitive to radiation damage as they can experience inter-mitotic 
death. Even mild radiation exposure can lead to a heavy drop in sperm numbers. 
Mature sperm that receive radiation damage can harbor serious mutations or 
chromosomal abnormalities, leading to severe birth defects in progeny. Exposure to 
female reproductive organs can even lead to miscarriage and early menopause. As a 
result, it usually recommended for patients who receive gonadal exposure practice 
birth control methods for up to six months after the exposure. Because the ovaries 
rely on a regular, cyclical production of hormones from the follicles, radiation 
injury can lead to more pronounced effects on fertility. Mucosal atrophy and drying 
of female genitalia can cause great discomfort for the patient as well. Thus, fertility 
treatment and consultation should be considered for patients who received heavy or 
repeated radiation exposure to the gonads [13, 14, 42].
6. Pediatrics
Pediatric patients are unique in that many organs and tissues are still develop-
ing. As a result, the cells involved are particularly sensitive to radiation damage as 
the fully developed adult organ can become abnormal or dysfunctional. Pediatric 
patients who receive radiation therapy are known to have a higher risk of develop-
ing growth abnormalities, chronic diseases, secondary malignancies and premature 
death compared to sibling controls [43]. Children who were treated with radio-
therapy in the pelvis for tumors such as rhabdomyosarcoma or germ cell tumors are 
at high risk for gonadal abnormalities. Given the rapid growth in the musculoskel-
etal system during puberty, exposure to the spine at an early age can cause drastic 
changes to the respiratory and cardiovascular system. Radiation exposure to any 
cartilage or bone not only presents the risk of bone necrosis, but also may affect 
the fully developed form of such tissue, sometimes resulting in stunted extremity 
length and increased frequency of fractures. Children treated for Wilms tumors are 
at high risk of renal abnormalities later in their lifetime to the remaining kidney, 
therefore attention to detail for renal health as these patients become adults is an 
important aspect of a survivorship plan. Exposure to the bowel and hepatic struc-
tures are known to adversely affect the growth and development of intraabdominal 
organs. These effects can affect nutritional intake, indirectly causing developmental 
issues as the child matures [14, 43, 44]. As these patients mature into adulthood, 
detailed review of a patient’s radiation exposure history will play a pivotal role in 
survivorship plans.
7. Mitigation strategies in planning
As many of the side effects of radiation therapy are difficult to anticipate and 
manage, a great deal of effort has been put into reducing the amount of non-tumor 
tissue exposed to radiation. In the early days of radiation, this was difficult simply 
due to the lack of technology. Now, most radiation oncologists have access to various 
new tools, such as 4-dimensional conformal avoidance techniques to minimize 
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off-target exposure [34]. Compact structures that were traditionally difficult to 
irradiate without significant off-target, such as the axilla and chest, can now be 
treated much more accurately with minimal exposure to non-tumor tissue [41]. 
Modern imaging techniques can be utilized to assess organ performance even before 
the administration of radiation to determine the risk of post-radiation symptoms. 
Indocyanine retention assays used in conjunction with MRI have determined the 
pre-exposure function of liver to assess if the patient is a good candidate for radia-
tion therapy [25]. New guidelines are constantly being updated to ensure that the 
risks of radiation therapy are minimized. Novel pharmacological agents, such as 
the development of immunotherapy, are being implemented to supplement the 
efficiency of radiation therapy. As medicine becomes more collaborative and data 
is more available, physicians outside of radiation oncology will be able to better 
understand the radiation therapy treatment plans and define survivorship care 
plans accordingly.
8. Conclusions
The discovery of nuclear power and the utilization to benefit humanity has been 
one of the defining moments of the modern era. While this discovery certainly 
has benefits, there are also unintended and intended consequences which we must 
continue to mitigate. In the field of medicine, what is clear is that radiation remains 
a crucial tool to diagnose and treat diseases. Understanding and minimizing the 
risks of using this tool remains a priority for the safety and well-being of patients, 
especially given the broad impact it has on organs throughout the body and the 
long-term effects. It falls upon health care professionals to remain vigilant and well-
informed to ensure that nuclear energy and radiation therapy remains a blessing 
and not a curse.
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